Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy

    Clinical Journal of the American Society of Nephrology Date published:

  • SP155aPLA2R RELATED PRIMARY MEMBRANOUS NEPHROPATHY IN CHILDREN AND ITS OUTCOME

    Nephrology Dialysis Transplantation Date published:

  • TO038TACROLIMUS WITH CORTICOSTEROIDS IS INFERIOR TO MODIFIED PONTICELLI REGIMEN IN THE MANAGEMENT OF PRIMARY MEMBRANOUS NEPHROPATHY: RESULTS AT 2 YEARS OF RANDOMIZATION

    Nephrology Dialysis Transplantation Date published:

  • Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study

    The Lancet Date published:

  • SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes

    Molecular Biology Reports Date published:

  • MP83-15 EFFECT OF GEMCITABINE AND MITOMYCIN ON CANCER STEM CELLS IN UROTHELIAL CARCINOMA CELLS

    Journal of Urology Date published:

  • Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells

    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Date published:

  • Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial

    Nephrology Date published:

  • Dialysis outcomes in India: Preliminary results from a prospective cohort study

    Date published:

  • AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STEM CELLS DOES HELP IN EARLY OSTEOARTHRITIS KNEE

    Date published:

  • CHOLECALCIFEROL SUPPLEMENTATION AND VASCULAR FUNCTION IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

    Date published:

  • First experience with donation after circulatory death transplantation program in India

    Date published:

  • Tacrolimus with corticosteroids is inferior to modified Ponticelli regimen in the management of primary membranous nephropathy: Results at 2 years of randomization

    Date published:

  • aPLA2R RELATED PRIMARY MEMBRANOUS NEPHROPATHY IN CHILDREN AND ITS OUTCOME

    Date published:

  • Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis

    Kidney International Date published:

  • Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor--related membranous nephropathy after tacrolimus therapy

    Kidney International Date published: